TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
PR Newswire
NEW YORK, Sept. 21, 2026
Expanded Partnership Strengthens Language Access and Provides Greater Visibility Across Evolent's Payer Network
Key Takeaways
- Enterprise-wide telephonic interpretation expands language access for members with limited English proficiency.
- Centralized reporting improves oversight of language services and supports compliance efforts.
- AI-enabled technology and professional interpreters deliver fast, reliable service.
NEW YORK, Sept. 21, 2026 /PRNewswire/ -- TransPerfect, the world's leading provider of language and AI solutions for global business, today announced it was selected by Evolent Health, Inc. to provide enterprise-wide telephonic interpretation services, expanding language access for health plan members with limited English proficiency (LEP) across Evolent's payer network.
This expanded partnership between the two organizations also gives Evolent visibility into utilization trends through centralized reporting and performance insights, supporting NCQA accreditation, regulatory compliance, Medicare and Medicaid requirements, and broader health equity initiatives. Powered by TransPerfect's hybrid model, the solution combines AI-enabled technology with professional interpreters to deliver efficient, high-quality support and the flexibility to meet a wide range of member needs.
"TransPerfect has supported Evolent's translation and interpretation needs, and we continue to receive positive feedback regarding the quality of services provided to the members we support," said Kristen Berquist, Evolent Senior Vice President of Corporate Operations. "Expanding this relationship will help us provide more consistent language access across our organization while giving our teams greater insight into how these services are being used."
TransPerfect President and Co-CEO Phil Shawe commented, "We value the trust Evolent has placed in TransPerfect and are pleased to expand our relationship. We look forward to supporting Evolent as it strengthens language access and continues serving the needs of its diverse member population."
For more news and announcements, visit the TransPerfect News & Press Center at www.transperfect.com/about/news-and-press.
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting www.evolent.com.
About TransPerfect
TransPerfect is the world's largest provider of language and AI solutions for global business. From offices in over 150 cities on six continents, TransPerfect offers a full range of services in 200+ languages to clients worldwide. More than 6,000 global organizations employ TransPerfect's GlobalLink® technology to simplify the management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.
SOURCE TransPerfect
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
What’s Ahead for Stocks This Quarter—and Where to Invest
United States